Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06BIE
|
|||
Former ID |
DNCL003259
|
|||
Drug Name |
PanBlok
|
|||
Synonyms |
PanBlok (TN)
Click to Show/Hide
|
|||
Indication | Pandemic influenza infection [ICD-11: 1E30] | Phase 2 | [1] | |
Influenza virus infection [ICD-11: 1E30-1E32] | Phase 1/2 | [2] | ||
Company |
Protein Sciences
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | ClinicalTrials.gov (NCT01612000) Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.